BridgeMD
New treatment option for Colorectal Carcinoma
Official title Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
ClinicalTrials.gov ID: NCT06926374
What this study is testing
- What it's testing
- Robotic assisted surgery has been performed for more than two decades with good success and safety profile. However, there was only one dominating robotic surgical system available in the past which led to high cost for robotic surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- General for All Procedures:
- Body mass index \<35 kg/m2
- Suitable for the listed minimally invasive surgical procedures for treatment of respective diseases
- Willingness to participate as demonstrated by giving informed consent General
You likely can't join if
- for All Procedures:
- Contraindication to general anesthesia
- Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
- Untreated active infection
- Noncorrectable coagulopathy
- Presence of another malignancy or distant metastasis
See the full eligibility criteria
- General for All Procedures:
- Body mass index \<35 kg/m2
- Suitable for the listed minimally invasive surgical procedures for treatment of respective diseases
- Willingness to participate as demonstrated by giving informed consent General
- for All Procedures:
- Contraindication to general anesthesia
- Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
- Untreated active infection
- Noncorrectable coagulopathy
- Presence of another malignancy or distant metastasis
- Emergency surgery
- Vulnerable population (e.g., mentally disabled, pregnancy) Robotic Colorectal Resection Inclusion Criteria: \- Adenocarcinoma or large adenoma (not amenable to endoscopic removal) located at the colorectum (from the...
- T4 tumor
- Recurrent tumor
- Extensive previous abdominal surgery precluding minimally invasive surgery Robotic Transanal Total Mesorectal Excision Inclusion Criteria: \- Mid/low rectal adenocarcinoma located \<12 cm from the anal verge Exclusion...
- T4 tumor or involvement of circumferential resection margin even after neoadjuvant therapy
- Tumor requiring multivisceral resection
- Tumor requiring abdominoperineal resection; recurrent rectal tumor
- T1 tumor that can be treated by local excision
- Extensive previous abdominal surgery Robotic Rectopexy Inclusion Criteria:
- Clinically diagnosed with previously untreated and uncomplicated rectal prolapse or enterocele Exclusion Criteria: \- Extensive previous abdominal surgery precluding minimally invasive surgery Radical Prostatectomy...
- Previous ipsilateral kidney surgery
- Complex kidney anatomy (e.g., horseshoe kidney, complex renal vascular anatomy) Radical Cystectomy Inclusion Criteria: \- Clinically diagnosed with nonmetastatic bladder cancer Robotic Esophageal Hiatal Surgery and...
- Acute cholecystitis
- Previous history of abdominal surgery
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.